News more>>
  11/17/2015    | BeiGene Receives 2015 R&D Achievement of Year at BayHelix China Pharmaceutical Awards
  11/09/2015    | BeiGene Appoints Dr. Zhengming Du as Senior Vice President, Head of Chemistry and Manufacturing Controls
  11/08/2015    | New, Investigational PARP1/2 Inhibitor BGB-290 Shows Promise
  11/02/2015    | BeiGene Announces Appointment of Dr. RuiRong Yuan as Chief Medical Officer and President of Global Clinical Development
  10/29/2015    | BeiGene Announces Abstracts to be Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  10/12/2015    | BeiGene Doses First Patient in China with BGB-283 for Solid Tumors
  09/30/2015    | BeiGene Appoints Changzhen Wu as Head of Manufacturing Operations
  09/25/2015    | BeiGene Appoints Dr. Jinyou Zhang as Senior Vice President, Head of Bioprocess Development and Manufacturing
  09/11/2015    | BeiGene Announces the Addition of Dr. Jedd D. Wolchok to Scientific Advisory Board
  08/20/2015    | BeiGene Signs Agreement with BioBAY for Its First cGMP Manufacturing Facility for Commercial Use in Suzhou, China
  08/12/2015    | BeiGene Announces Appointment of Dr. Howard Liang as Chief Financial and Strategy Officer
  07/31/2015    | BeiGene Receives Approval to Initiate Clinical Trials in China with BGB-283 for Solid Tumor Cancers
  07/13/2015    | BeiGene Doses First Patient in Phase Ib Study of BGB-283, A Novel Second Generation B-RAF inhibitor
  06/19/2015    | BeiGene Announces IND Clearance for BGB-3111, a Bruton tyrosine kinase inhibitor
  06/05/2015    | BeiGene Enrolls First Patient in Phase I Study of BGB-A317, A Humanized Anti-PD-1 Monoclonal Antibody
  05/27/2015    | Make the World’s Best Anti-cancer Drugs (Dream Chaser)
  05/13/2015    | BeiGene Secures 600 Million RMB ($97 Million US) Financing
  04/07/2015    | BeiGene Announces Presentations at AACR Annual Meeting 2015
  03/11/2015    | China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development
  02/25/2015    | BeiGene to Present at the Cowen and Company 35th Annual Health Care Conference
  02/10/2015    | BeiGene to Present at the BIO CEO Investor Conference
  01/30/2015    | Dr. Jason Yang spoke at 4th Annual Clinical Development and Trials Asia Congress & 5th Annual Pharma R&D Asia Congress
  01/08/2015    | BeiGene to Present at the 33rd Annual J.P. Morgan Healthcare Conference
  12/09/2014    | BeiGene Announces Presentation at The American Society of Hematology Annual Meeting 2014
  11/14/2014    | BeiGene Completes 450 Million RMB (75 Million USD) Financing
  11/11/2014    | Dr. Jason Yang, Senior Vice President of Clinical Development spoke at ChinaTrials 7 Summit
Copyright BeiGene LTD    |   Careers   |    Contact Us